Iowa joins Maine and Vermont in Rx drug pool

13 August 2006

The mid-western US State of Iowa is to unite with the northeastern states of Maine and Vermont in a purchasing pool for prescription drugs for their Medicaid beneficiaries, according to an announcement by Iowa's Governor Tom Vilsack (Democrat).

Gov Vilsack, who is standing down after eight years in the position later this year, said: "together our group of states will achieve pharmaceutical rebates that will far exceed the amount that each state could provide on their own."

According to 2005 population estimates by the US Census Bureau, Iowa's population of just under three million was the 30th-ranked out of 50. Maine and Vermont between them have approximately the same population as Iowa. Taken together, the combined population would place them at about 16th rank by population in the USA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight